×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
3670 views

Modérateur : Alexandre de Nonneville

Au programme de cette soirée

18:00 Introduction
 
18:05 Traitements de première ligne - études immuno, statut PDL1...
Fanny Le Du
 
18:25 La place des anticorps conjugués à ce jour - accès précoces actuels et utilisation pratique (tolérance, sécurité)
Marie Beguinot
 
18:45 ADC : un développement exponentiel et la remontée des lignes
Thomas Grinda
 
19:05 Résistances aux ADC, données actuelles et perspectives
Alexandre de Nonneville
 
19:25 Débat/discussion - Réponses aux questions
 

 


Webinar #2   Webinar #3

 

Shooting date : 2024-01-18
Last update : 2024-04-03

Suggestions

Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Honolulu : Friday, February 9th 2024 from 06:30am to 08am (GMT+1)
San Francisco : Friday, February 9th 2024 from 08:30am to 10am (GMT+1)
New York : Friday, February 9th 2024 from 11:30am to 01pm (GMT+1)
Buenos Aires : Friday, February 9th 2024 from 01:30pm to 03pm (GMT+1)
London / Dublin : Friday, February 9th 2024 from 04:30pm to 06pm (GMT+1)
Paris / Berlin : Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Istanbul : Friday, February 9th 2024 from 06:30pm to 08pm (GMT+1)
Moscou / Dubaï : Friday, February 9th 2024 from 08:30pm to 10pm (GMT+1)
Bangkok : Friday, February 9th 2024 from 11:30pm to 01am (GMT+1)
Shanghai : Saturday, February 10th 2024 from 12:30am to 02am (GMT+1)
Tokyo : Saturday, February 10th 2024 from 01:30am to 03am (GMT+1)
Sydney : Saturday, February 10th 2024 from 02:30am to 04am (GMT+1)
Wellington : Saturday, February 10th 2024 from 04:30am to 06am (GMT+1)

Le réseau FEM-NET, position du problème pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up